Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Breast Milk in Hypoxic-ischaemic Encephalopathy
NCT06747260Phase 1Recruiting
- Sponsor
- Semmelweis University
- Start
- Nov 2024
- Primary completion
- Sep 2025
- Modality
- Nutraceutical
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of human milk in hypoxic-ischemic encephalopathy (HIE), sponsored by Semmelweis University. Primary endpoint: Proportion of patients where treatment was initiated within 48 hours. Started Nov 2024; status: recruiting.
02
Drugs
human milk
03
Conditions
hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on NCT06747260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06747260.